Nana

The Two-Decade Vigil: Shira Kolat’s Journey from Genetic Previvorship to Triple-Negative Breast Cancer Survival

• Patient Advocacy and Support

The Two-Decade Vigil: Shira Kolat’s Journey from Genetic Previvorship to Triple-Negative Breast Cancer Survival

Nana July 1, 2026

GAITHERSBURG, MD – For most twenty-somethings, life is a sequence of milestones involving career starts, social engagements,...

Read More Read more about The Two-Decade Vigil: Shira Kolat’s Journey from Genetic Previvorship to Triple-Negative Breast Cancer Survival

Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Rare Patent Lapse

• Treatment Innovations

Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Rare Patent Lapse

Nana June 30, 2026

In a landmark development for global pharmaceutical markets, Canada has officially become the first G7 nation to...

Read More Read more about Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Rare Patent Lapse

From Survival to Solidarity: How One Woman’s Journey Redefined the Meaning of Care

• Integrative Oncology and Holistic Care

From Survival to Solidarity: How One Woman’s Journey Redefined the Meaning of Care

Nana June 29, 2026

Introduction: The Courage to Be Seen For most, the journey toward authenticity is a personal evolution. For...

Read More Read more about From Survival to Solidarity: How One Woman’s Journey Redefined the Meaning of Care

Ollin Biosciences Secures $330 Million to Advance Groundbreaking Ophthalmic Therapies into Global Phase III Trials

• Medical Research and Clinical Trials

Ollin Biosciences Secures $330 Million to Advance Groundbreaking Ophthalmic Therapies into Global Phase III Trials

Nana June 29, 2026

Boston, MA – June 25, 2024 – Ollin Biosciences, a pioneering biopharmaceutical company dedicated to revolutionizing ophthalmology,...

Read More Read more about Ollin Biosciences Secures $330 Million to Advance Groundbreaking Ophthalmic Therapies into Global Phase III Trials

Beyond the Diagnosis: Why Confronting Mortality Is the Ultimate Act of Living

• Survivorship and Post-Treatment

Beyond the Diagnosis: Why Confronting Mortality Is the Ultimate Act of Living

Nana June 28, 2026

By Editorial Staff May 26, 2026 In the book of Deuteronomy, the ancient imperative is clear: "Choose...

Read More Read more about Beyond the Diagnosis: Why Confronting Mortality Is the Ultimate Act of Living

Scientific Breakthroughs and Institutional Turmoil: The 2026 American Diabetes Association Conference

• Treatment Innovations

Scientific Breakthroughs and Institutional Turmoil: The 2026 American Diabetes Association Conference

Nana June 27, 2026

The 2026 American Diabetes Association (ADA) national conference was intended to be a watershed moment for the...

Read More Read more about Scientific Breakthroughs and Institutional Turmoil: The 2026 American Diabetes Association Conference

Bridging the Gap: MGS Scales Hybrid Tooling to Revolutionize Medical Device Development

• Treatment Innovations

Bridging the Gap: MGS Scales Hybrid Tooling to Revolutionize Medical Device Development

Nana June 27, 2026

In the high-stakes world of medical device manufacturing, the path from a revolutionary design concept to a...

Read More Read more about Bridging the Gap: MGS Scales Hybrid Tooling to Revolutionize Medical Device Development

The Global Blood Divide: WHO Report Exposes Critical Gaps in Life-Saving Transfusion Systems

• Breast Cancer Prevention and Lifestyle

The Global Blood Divide: WHO Report Exposes Critical Gaps in Life-Saving Transfusion Systems

Nana June 27, 2026

By Global Health Correspondent In an era of rapid medical advancement, a fundamental disparity continues to dictate...

Read More Read more about The Global Blood Divide: WHO Report Exposes Critical Gaps in Life-Saving Transfusion Systems

Moderna Charts Ambitious Future for mRNA Platform, Highlighting ‘Horizon’ Programs and Novel In Vivo Candidate

• Medical Research and Clinical Trials

Moderna Charts Ambitious Future for mRNA Platform, Highlighting ‘Horizon’ Programs and Novel In Vivo Candidate

Nana June 27, 2026

Boston, MA – June 26, 2024 – Moderna, a pioneer in messenger RNA (mRNA) therapeutics, today unveiled...

Read More Read more about Moderna Charts Ambitious Future for mRNA Platform, Highlighting ‘Horizon’ Programs and Novel In Vivo Candidate

AI-Driven Radiology: Aidoc’s ‘First Read’ Receives FDA Breakthrough Designation to Combat Imaging Backlogs

• Treatment Innovations

AI-Driven Radiology: Aidoc’s ‘First Read’ Receives FDA Breakthrough Designation to Combat Imaging Backlogs

Nana June 26, 2026

In a significant move to alleviate the mounting pressure on global healthcare systems, the US Food and...

Read More Read more about AI-Driven Radiology: Aidoc’s ‘First Read’ Receives FDA Breakthrough Designation to Combat Imaging Backlogs